Who is Manish Anandani, Colgate-Palmolive India’s incoming MD & CEO?
Manish Anandani will become MD & CEO of Colgate-Palmolive India on September 28, 2026, succeeding Prabha Narasimhan. He previously worked at Colgate for 13 years and later at Johnson & Johnson and Kenvue. Colgate aims to grow through premiumization and digital commerce, with Anandani's experience aligning with these strategies.
How this was made
The 30-second read
Why it matters
The appointment could affect execution of growth initiatives but lacks immediate financial data.
Market read
Executive change may influence Colgate's Indian market performance and investor sentiment.
What to watch
Potential integration challenges from his health‑care background.
Background
Colgate-Palmolive is expanding premium oral‑care and e‑commerce in India.
Ticker impact
Manish Anandani appointed MD & CEO of Colgate-Palmolive India effective Sep 28, 2026.
Modest short‑term volatility, potential upside if premiumisation plan succeeds.
First‑time appointment of a known insider; no immediate financial metrics disclosed.
Market effects
May reinforce premiumisation trends in Indian FMCG sector.
Signals continued focus on digital commerce in India.
Limited; primarily India‑focused consumer goods impact.
Counterpoint
Leadership continuity may already be priced in; no material change to fundamentals.
Key entities
- ExecutiveManish Anandani
Incoming MD & CEO of Colgate-Palmolive India.
- ExecutivePrabha Narasimhan
Outgoing MD & CEO, moving to EVP‑Marketing Asia‑Pacific.



